New England Capital Financial Advisors LLC Arvinas, Inc. Transaction History

New England Capital Financial Advisors LLC

$193 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 03, 2023	BUY	$32.47 - $57.24 $32,470 - $57,240	1,000 New	1,000 $33.5 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$131 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$126 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$117 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$72.2 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$52.1 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $997M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Capital Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Capital Financial Advisors LLC with notifications on news.

Account